ZONTIVITY

This brand name is authorized in Estonia, Lithuania, Romania, United States

Active ingredients

The drug ZONTIVITY contains one active pharmaceutical ingredient (API):

1 Vorapaxar UNII IN66038E6C - VORAPAXAR SULFATE

Vorapaxar is a selective and reversible inhibitor of the PAR-1 receptors on platelets that are activated by thrombin. Read about Vorapaxar

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZONTIVITY Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC26		B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1676202, 1676213, 1676224, 1676235, 1676246, 1676257
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075820, 1075821, 1075822, 1075823, 1075824, 1075825
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61976001, W61976002, W61976003, W61976004, W61976005, W61976006
Country: US	FDA, National Drug Code	Identifier(s): 70347-208